title: Oncology nursing support for safe and effective use of eribulin in metastatic breast cancer.
abstract: Nurse practitioners play important roles in breast cancer prevention, early detection, therapeutic efficacy, and surveillance. Assessment of a patient's health status is part of the nine nurse practitioner core competencies updated in 2012 by the National Organization of Nurse Practitioner Faculties. Although adverse events are common in treatment for metastatic breast cancer (MBC), proactive management strategies can limit the number and/or severity of adverse events. Additionally, knowledge of common metastatic sites and clinical signs/symptoms of recurrence provides one of the first-line strategies for successful treatment. We review five case studies of women with MBC who were managed successfully with eribulin mesylate in late lines of therapy after at least two chemotherapeutic regimens for advanced breast cancer that included both an anthracycline and a taxane in either the adjuvant or metastatic setting.
authors.affiliation: Weill Cornell Breast Center, New York, NY, USA.
authors.forename: Diana
authors.initials: D
authors.lastname: Donovan
authors.affiliation: Department of Medicine, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
authors.forename: Laura
authors.initials: L
authors.lastname: Urquhart
authors.affiliation: Dickstein Cancer Center, White Plains Hospital, White Plains, NY, USA.
authors.forename: Una
authors.initials: U
authors.lastname: Hopkins
authors.affiliation: Mary Bird Perkins Cancer Center, Baton Rouge, LA, USA.
authors.forename: Sandra
authors.initials: S
authors.lastname: Knight
authors.affiliation: Department of Anesthesia and Perioperative Medicine, University Hospitals of Cleveland, Cleveland, OH, USA.
authors.forename: Laura
authors.initials: L
authors.lastname: Moore
keywords: distant breast cancer metastases; eribulin; eribulin-related AE management; metastatic breast cancer